Annual Operating Profit
-$31.11 M
-$2.87 M-10.16%
December 31, 2023
Summary
- As of February 26, 2025, RGLS annual operating income is -$31.11 million, with the most recent change of -$2.87 million (-10.16%) on December 31, 2023.
- During the last 3 years, RGLS annual operating profit has fallen by -$16.95 million (-119.77%).
- RGLS annual operating profit is now -335.88% below its all-time high of -$7.14 million, reached on December 31, 2011.
Performance
RGLS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$15.21 M
-$2.95 M-24.06%
September 30, 2024
Summary
- As of February 26, 2025, RGLS quarterly operating income is -$15.21 million, with the most recent change of -$2.95 million (-24.06%) on September 30, 2024.
- Over the past year, RGLS quarterly operating profit has stayed the same.
- RGLS quarterly operating profit is now -1463.21% below its all-time high of -$973.00 thousand, reached on September 30, 2011.
Performance
RGLS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$44.60 M
-$7.08 M-18.89%
September 30, 2024
Summary
- As of February 26, 2025, RGLS TTM operating income is -$44.60 million, with the most recent change of -$7.08 million (-18.89%) on September 30, 2024.
- Over the past year, RGLS TTM operating profit has stayed the same.
- RGLS TTM operating profit is now -4483.35% below its all-time high of -$973.00 thousand, reached on September 30, 2011.
Performance
RGLS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RGLS Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.2% | 0.0% | 0.0% |
| 3 y3 years | -119.8% | -112.0% | -53.1% |
| 5 y5 years | +33.5% | -204.6% | -209.3% |
RGLS Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.8% | at low | -131.5% | at low | -60.3% | at low |
| 5 y | 5-year | -119.8% | at low | -1378.1% | at low | -215.1% | at low |
| alltime | all time | -335.9% | +61.8% | -1463.2% | +28.9% | -4483.4% | +45.3% |
Regulus Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$15.21 M(+24.1%) | -$44.60 M(+18.9%) |
| Jun 2024 | - | -$12.26 M(+38.9%) | -$37.51 M(+15.2%) |
| Mar 2024 | - | -$8.83 M(+6.3%) | -$32.57 M(+4.7%) |
| Dec 2023 | -$31.11 M(+10.2%) | -$8.30 M(+2.2%) | -$31.11 M(+4.6%) |
| Sep 2023 | - | -$8.13 M(+11.1%) | -$29.74 M(+1.9%) |
| Jun 2023 | - | -$7.32 M(-0.7%) | -$29.18 M(+0.5%) |
| Mar 2023 | - | -$7.37 M(+6.3%) | -$29.04 M(+2.8%) |
| Dec 2022 | -$28.24 M(+1.5%) | -$6.93 M(-8.3%) | -$28.24 M(-0.1%) |
| Sep 2022 | - | -$7.56 M(+5.4%) | -$28.27 M(-2.9%) |
| Jun 2022 | - | -$7.17 M(+9.2%) | -$29.12 M(+1.9%) |
| Mar 2022 | - | -$6.57 M(-5.6%) | -$28.59 M(+2.8%) |
| Dec 2021 | -$27.82 M(+96.5%) | -$6.96 M(-17.3%) | -$27.82 M(+27.1%) |
| Sep 2021 | - | -$8.42 M(+26.8%) | -$21.88 M(+50.3%) |
| Jun 2021 | - | -$6.64 M(+14.5%) | -$14.56 M(+1.0%) |
| Mar 2021 | - | -$5.80 M(+463.5%) | -$14.42 M(+1.9%) |
| Dec 2020 | -$14.15 M(-15.9%) | -$1.03 M(-6.0%) | -$14.15 M(-19.4%) |
| Sep 2020 | - | -$1.09 M(-83.1%) | -$17.56 M(-18.2%) |
| Jun 2020 | - | -$6.50 M(+17.4%) | -$21.46 M(+9.3%) |
| Mar 2020 | - | -$5.54 M(+24.8%) | -$19.63 M(+16.6%) |
| Dec 2019 | -$16.83 M(-64.0%) | -$4.43 M(-11.2%) | -$16.83 M(-17.4%) |
| Sep 2019 | - | -$4.99 M(+7.0%) | -$20.38 M(-19.3%) |
| Jun 2019 | - | -$4.67 M(+70.5%) | -$25.24 M(-25.6%) |
| Mar 2019 | - | -$2.74 M(-65.7%) | -$33.92 M(-27.5%) |
| Dec 2018 | -$46.76 M(-33.3%) | -$7.98 M(-19.0%) | -$46.76 M(-10.9%) |
| Sep 2018 | - | -$9.85 M(-26.2%) | -$52.49 M(-9.6%) |
| Jun 2018 | - | -$13.34 M(-14.4%) | -$58.05 M(-12.1%) |
| Mar 2018 | - | -$15.58 M(+13.7%) | -$66.02 M(-5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$70.13 M(-14.0%) | -$13.71 M(-11.1%) | -$70.13 M(-7.9%) |
| Sep 2017 | - | -$15.41 M(-27.7%) | -$76.17 M(-4.7%) |
| Jun 2017 | - | -$21.32 M(+8.2%) | -$79.94 M(+0.2%) |
| Mar 2017 | - | -$19.69 M(-0.3%) | -$79.82 M(-2.1%) |
| Dec 2016 | -$81.50 M(+48.8%) | -$19.74 M(+2.9%) | -$81.50 M(+17.9%) |
| Sep 2016 | - | -$19.19 M(-9.4%) | -$69.12 M(+9.2%) |
| Jun 2016 | - | -$21.19 M(-0.9%) | -$63.27 M(+0.0%) |
| Mar 2016 | - | -$21.38 M(+190.4%) | -$63.27 M(+15.5%) |
| Dec 2015 | -$54.76 M(+21.9%) | -$7.36 M(-44.8%) | -$54.76 M(-3.8%) |
| Sep 2015 | - | -$13.35 M(-37.0%) | -$56.93 M(+3.1%) |
| Jun 2015 | - | -$21.18 M(+64.6%) | -$55.24 M(+17.4%) |
| Mar 2015 | - | -$12.87 M(+35.0%) | -$47.08 M(+4.8%) |
| Dec 2014 | -$44.91 M(+152.3%) | -$9.53 M(-18.2%) | -$44.91 M(+12.2%) |
| Sep 2014 | - | -$11.66 M(-10.4%) | -$40.04 M(+28.0%) |
| Jun 2014 | - | -$13.01 M(+21.6%) | -$31.29 M(+36.3%) |
| Mar 2014 | - | -$10.71 M(+129.6%) | -$22.96 M(+29.0%) |
| Dec 2013 | -$17.80 M(+41.6%) | -$4.66 M(+60.5%) | -$17.80 M(+2.1%) |
| Sep 2013 | - | -$2.90 M(-38.0%) | -$17.44 M(-3.5%) |
| Jun 2013 | - | -$4.69 M(-15.6%) | -$18.07 M(+13.3%) |
| Mar 2013 | - | -$5.55 M(+29.0%) | -$15.94 M(+26.8%) |
| Dec 2012 | -$12.57 M(+76.2%) | -$4.30 M(+21.8%) | -$12.57 M(+23.9%) |
| Sep 2012 | - | -$3.53 M(+38.1%) | -$10.15 M(+33.7%) |
| Jun 2012 | - | -$2.56 M(+17.3%) | -$7.59 M(+50.9%) |
| Mar 2012 | - | -$2.18 M(+16.2%) | -$5.03 M(+76.5%) |
| Dec 2011 | -$7.14 M(-53.9%) | -$1.88 M(+92.8%) | -$2.85 M(+192.8%) |
| Sep 2011 | - | -$973.00 K | -$973.00 K |
| Dec 2010 | -$15.50 M | - | - |
FAQ
- What is Regulus Therapeutics annual operating income?
- What is the all time high annual operating profit for Regulus Therapeutics?
- What is Regulus Therapeutics annual operating profit year-on-year change?
- What is Regulus Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly operating profit year-on-year change?
- What is Regulus Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Regulus Therapeutics?
- What is Regulus Therapeutics TTM operating profit year-on-year change?
What is Regulus Therapeutics annual operating income?
The current annual operating profit of RGLS is -$31.11 M
What is the all time high annual operating profit for Regulus Therapeutics?
Regulus Therapeutics all-time high annual operating income is -$7.14 M
What is Regulus Therapeutics annual operating profit year-on-year change?
Over the past year, RGLS annual operating income has changed by -$2.87 M (-10.16%)
What is Regulus Therapeutics quarterly operating income?
The current quarterly operating profit of RGLS is -$15.21 M
What is the all time high quarterly operating profit for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly operating income is -$973.00 K
What is Regulus Therapeutics quarterly operating profit year-on-year change?
Over the past year, RGLS quarterly operating income has changed by $0.00 (0.00%)
What is Regulus Therapeutics TTM operating income?
The current TTM operating profit of RGLS is -$44.60 M
What is the all time high TTM operating profit for Regulus Therapeutics?
Regulus Therapeutics all-time high TTM operating income is -$973.00 K
What is Regulus Therapeutics TTM operating profit year-on-year change?
Over the past year, RGLS TTM operating income has changed by $0.00 (0.00%)